Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Had sent email to IR saying dissatisfied with options award. Received this reply from IR
"I have received your letter and thank you for your support of 4D pharma over the years. It is very important to us to hear the view of our shareholders.
As with many publicly traded companies, stock awards at the start of a new year are part of the normal course of business and is standard practice for building shareholder value. This is especially true as we strive to retain our staff who have the expertise and capabilities to deliver on our mission to bring safe and effective therapies via the microbiome. Additionally, as we continue to develop our clinical programs building on the encouraging data that has been released over the last year across multiple programs, we seek to recruit talent to support this progress, particularly in the US, where stock awards are an essential and expected part of any remuneration in the biotech industry.
We are exceptionally proud at 4D pharma to have such a committed and competent team, and recognising this through competitive and fair option schemes is a key part of ensuring we continue to lead the way in microbiome therapeutics. The 4D Stock Option program has been benchmarked by outside agencies and is comparable to companies with a similar market capitalization. Further, it is important to recognise these stock option awards will vest over a period of 4 years, and our employees will only see a benefit if the share price performs over that period - which is what we all want to see.
We are consciously aware that our positive results from both the lab and the clinic over the last year or so are happening in the context of extremely tough market conditions, not just for 4D pharma but for the healthcare sector as a whole, with 2021 ranking as one of the worst performing years for a number of years.
We continue to make progress with our live biotherapeutic programs, with more data and new trials expected during 2022, all of which will add further validation and value to our MicroRx platform, and we look forward to updating our shareholders throughout the year as we make further progress.
Best regards,
Axel Glasmacher
Non-Executive Chairperson"
Hope you are right and it is good news. Been very silent here.
It has been quite for a while now. Does anyone have any update on vanadium mine or PEL license application or any update at all?
Sunlit / nightgaunt
How do I get included in email distribution list. Would love to see what Chinese have to offer before deciding which way to vote.
Sunlit,
I would love to see the email if that is possible.
Are you on twitter? if so i could follow you and can DM you my email address.
We are coming to last week of October and still no news re: permits. anyone have any idea whats going on?
Has anyone tried contacting NL?
Hope you are right FourP. News has been long overdue.
I have been invested in this share for far too long and have seen lots of ups/down, Rampers/derampers. But never had to or wanted to post. Everyone here has been patience for long enough. i am seriously hoping we get the positive news re; coal and if JV comes than it is a bonus.
Range1 question raised by warrant is a genuine one and I would also like to know why you think this is such a good appointment?